lily glp 1 Lilly's diabetes drug ahead of Novo Nordisk's in Q2 market share < Pharma < Article Eli Lilly says its experimental
Description
Special focus on GLP-1 products
GLP-1 medications typically require 12 weeks at the target therapeutic dose to assess effectiveness
In terms of reduction in BMI, 11 studies (with 349 and 310 subjects from the experimental and control groups, respectively) were included in the analysis
Recent studies suggest that GLP-1 also mediates the metabolic effects of metformin, gut microbiota, and bariatric surgery 3,4,5,6
Its important to recognize the broader effects and consider that patients may benefit even if they dont lose a significant amount of weight
Participants completed original and adapted forms of validated assessments (see Supplemental document)
